A recent study revealed a significant effect of the immunotherapy agent enoblituzumab (try pronouncing that one..) for high-risk prostate cancer patients:
There are a number of other articles about it - the use isn't only in prostate cancer, but it seemed to have the best results in high-risk prostate cancer patients
“Twenty-one patients, or 66%, had an undetectable prostate-specific antigen (PSA) level 12 months following surgery, suggesting that there was no sign of residual disease. Additionally, the drug was well-tolerated overall; no patients had any surgical delays or medical complications during or after the operatio”
Yes, this is very good NEWS!
We must also remember these were very Advanced PCa cases. I saved the article, although I am 2 yrs-4mos since Dx, and 1 yr-5mos since SABR of Prostate. The MAB Drugs seem to hold promise for extension of life, which brings us one step closer to extended remission. Mike
I read about this too. It's a very impressive outcome considering all patients were Gleason 8, 9, or 10. It may be the drug of the future for prostate cancer.
Why aren't we hearing more about Enoblituzumab? I read a phase 3 trial is planned but have not heard anything else.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Good news, not so good news...
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer
Bone scan results
